118 related articles for article (PubMed ID: 21834791)
41. A fluorometric method to quantify protein glutathionylation using glutathione derivatization with 2,3-naphthalenedicarboxaldehyde.
Menon D; Board PG
Anal Biochem; 2013 Feb; 433(2):132-6. PubMed ID: 23072983
[TBL] [Abstract][Full Text] [Related]
42. Novel role for glutathione S-transferase pi. Regulator of protein S-Glutathionylation following oxidative and nitrosative stress.
Townsend DM; Manevich Y; He L; Hutchens S; Pazoles CJ; Tew KD
J Biol Chem; 2009 Jan; 284(1):436-445. PubMed ID: 18990698
[TBL] [Abstract][Full Text] [Related]
43. Doxorubicin induces the acetylation of histone H1 in a human colon cancer cell line (LoVo/DX) selected for resistance to the drug, but not in the sensitive parental line (LoVo).
Mannironi C; D'Incalci M
Biochem Biophys Res Commun; 1988 Sep; 155(3):1221-9. PubMed ID: 3178805
[TBL] [Abstract][Full Text] [Related]
44. PABA/NO lead optimization: Improved targeting of cytotoxicity to glutathione S-transferase P1-overexpressing cancer cells.
Kim Y; Maciag AE; Cao Z; Deschamps JR; Saavedra JE; Keefer LK; Holland RJ
Bioorg Med Chem; 2015 Aug; 23(15):4980-4988. PubMed ID: 26043946
[TBL] [Abstract][Full Text] [Related]
45. Qualitatively different mechanisms of resistance to doxorubicin, both involving altered glutathione pools, in two myeloid cell lines in vitro.
Dajani LK; Warren DJ; Andersen A; Strømhaug A; Slørdal L
Pediatr Hematol Oncol; 1995; 12(6):531-44. PubMed ID: 8588998
[TBL] [Abstract][Full Text] [Related]
46. The redox state of cytochrome c modulates resistance to methotrexate in human MCF7 breast cancer cells.
Barros S; Mencia N; Rodríguez L; Oleaga C; Santos C; Noé V; Ciudad CJ
PLoS One; 2013; 8(5):e63276. PubMed ID: 23675469
[TBL] [Abstract][Full Text] [Related]
47. Nitrogen monoxide (NO) storage and transport by dinitrosyl-dithiol-iron complexes: long-lived NO that is trafficked by interacting proteins.
Suryo Rahmanto Y; Kalinowski DS; Lane DJ; Lok HC; Richardson V; Richardson DR
J Biol Chem; 2012 Mar; 287(10):6960-8. PubMed ID: 22262835
[TBL] [Abstract][Full Text] [Related]
48. Side Effects of Curcumin: Epigenetic and Antiproliferative Implications for Normal Dermal Fibroblast and Breast Cancer Cells.
Cianfruglia L; Minnelli C; Laudadio E; Scirè A; Armeni T
Antioxidants (Basel); 2019 Sep; 8(9):. PubMed ID: 31505772
[TBL] [Abstract][Full Text] [Related]
49. Nitric oxide donor doxorubicins accumulate into Doxorubicin-resistant human colon cancer cells inducing cytotoxicity.
Chegaev K; Riganti C; Lazzarato L; Rolando B; Guglielmo S; Campia I; Fruttero R; Bosia A; Gasco A
ACS Med Chem Lett; 2011 Jul; 2(7):494-7. PubMed ID: 24900337
[TBL] [Abstract][Full Text] [Related]
50. Nitric oxide: perspectives and emerging studies of a well known cytotoxin.
Paradise WA; Vesper BJ; Goel A; Waltonen JD; Altman KW; Haines GK; Radosevich JA
Int J Mol Sci; 2010 Jul; 11(7):2715-45. PubMed ID: 20717533
[TBL] [Abstract][Full Text] [Related]
51. Corrigendum: Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells.
Wang X; Hui R; Chen Y; Wang W; Chen Y; Gong X; Jin J
Front Pharmacol; 2020; 11():603491. PubMed ID: 33381044
[TBL] [Abstract][Full Text] [Related]
52. Light-Responsive Biodegradable Nanomedicine Overcomes Multidrug Resistance via NO-Enhanced Chemosensitization.
Fan J; He Q; Liu Y; Zhang F; Yang X; Wang Z; Lu N; Fan W; Lin L; Niu G; He N; Song J; Chen X
ACS Appl Mater Interfaces; 2016 Jun; 8(22):13804-11. PubMed ID: 27213922
[TBL] [Abstract][Full Text] [Related]
53. A pH-Responsive Carrier System that Generates NO Bubbles to Trigger Drug Release and Reverse P-Glycoprotein-Mediated Multidrug Resistance.
Chung MF; Liu HY; Lin KJ; Chia WT; Sung HW
Angew Chem Int Ed Engl; 2015 Aug; 54(34):9890-3. PubMed ID: 26136242
[TBL] [Abstract][Full Text] [Related]
54. Generic synthesis of small-sized hollow mesoporous organosilica nanoparticles for oxygen-independent X-ray-activated synergistic therapy.
Fan W; Lu N; Shen Z; Tang W; Shen B; Cui Z; Shan L; Yang Z; Wang Z; Jacobson O; Zhou Z; Liu Y; Hu P; Yang W; Song J; Zhang Y; Zhang L; Khashab NM; Aronova MA; Lu G; Chen X
Nat Commun; 2019 Mar; 10(1):1241. PubMed ID: 30886142
[TBL] [Abstract][Full Text] [Related]
55. Low-intensity focused ultrasound (LIFU)-activated nanodroplets as a theranostic agent for noninvasive cancer molecular imaging and drug delivery.
Liu J; Xu F; Huang J; Xu J; Liu Y; Yao Y; Ao M; Li A; Hao L; Cao Y; Hu Z; Ran H; Wang Z; Li P
Biomater Sci; 2018 Nov; 6(11):2838-2849. PubMed ID: 30229771
[TBL] [Abstract][Full Text] [Related]
56. High F-Content Perfluoropolyether-Based Nanoparticles for Targeted Detection of Breast Cancer by
Zhang C; Moonshi SS; Wang W; Ta HT; Han Y; Han FY; Peng H; Král P; Rolfe BE; Gooding JJ; Gaus K; Whittaker AK
ACS Nano; 2018 Sep; 12(9):9162-9176. PubMed ID: 30118590
[TBL] [Abstract][Full Text] [Related]
57. Hypoxia-specific therapeutic agents delivery nanotheranostics: A sequential strategy for ultrasound mediated on-demand tritherapies and imaging of cancer.
Feng Q; Li Y; Yang X; Zhang W; Hao Y; Zhang H; Hou L; Zhang Z
J Control Release; 2018 Apr; 275():192-200. PubMed ID: 29474964
[TBL] [Abstract][Full Text] [Related]
58. Organic Semiconducting Photoacoustic Nanodroplets for Laser-Activatable Ultrasound Imaging and Combinational Cancer Therapy.
Tang W; Yang Z; Wang S; Wang Z; Song J; Yu G; Fan W; Dai Y; Wang J; Shan L; Niu G; Fan Q; Chen X
ACS Nano; 2018 Mar; 12(3):2610-2622. PubMed ID: 29451774
[TBL] [Abstract][Full Text] [Related]
59. A glutathione-responsive sulfur dioxide polymer prodrug as a nanocarrier for combating drug-resistance in cancer chemotherapy.
Shen W; Liu W; Yang H; Zhang P; Xiao C; Chen X
Biomaterials; 2018 Sep; 178():706-719. PubMed ID: 29433753
[TBL] [Abstract][Full Text] [Related]
60. A review of hydrogen sulfide (H
Powell CR; Dillon KM; Matson JB
Biochem Pharmacol; 2018 Mar; 149():110-123. PubMed ID: 29175421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
